Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key
diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.


The Centers for Disease Control and Prevention (CDC) provides these overall estimates for diabetes and prediabetes:

  • 29.1 million people in the US with diabetes
    • 21.1 million are diagnosed
    • 8.0 million are undiagnosed
  • 86 million (or 1 of every 3) US adults aged 20 years or older have prediabetes
    • only 1 in 8 know they have prediabetes
  • Among adults aged 65 and older, 1 in 4 (26%) has diabetes and 1 in 2 (51%) has prediabetes.
  • The total cost of diabetes – for prediabetes, diagnosed and undiagnosed diabetes, and gestational diabetes – was estimated to be $322 billion in 2012. For diagnosed diabetes alone, the total cost was estimated to be $245 billion ($176 billion in direct costs and $69 billion for indirect costs).

More information is available here:

CDC’s 2014 National Diabetes Statistics Report and 2014 National Diabetes Report Card

Dall T, Yang W, Halder P, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014;37(12):3172-3179.

American Diabetes Association, The Cost of Diabetes

Diabetes Prevalence and Costs: Projections through 2030
July 11, 2016

The Institute for Alternative Futures (IAF) has published the results of a new study of diabetes prevalence and costs for the US as a whole, each of the 50 states, and several major metropolitan areas, with data for 2015, 2020, 2025 and 2030. Novo Nordisk commissioned the study and data were published online in 2016 in the peer-reviewed journal Population Health Management. Data tables and information can be downloaded here from the IAF site.